Predictors of hepatic decompensation after TACE for hepatocellular carcinoma.

Patients with a STATE score ≥18 had a median survival of 21 months, while those with a STATE score <18 had a median survival of 9 months; the difference was highly significant with a p value <0.001.

also in 132,142 other papers

Although a fall in platelet count after TACE (generally due to an increase in portal hypertension, drug toxicity or both) has been observed by a number of other authors, 24 29–32 in our study, the reduction in platelet count did not reach statistical significance.

also in 111,027 other papers